ASELAGE STEVE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 2, 2022
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Common Stock
2022-02-28$16.61/sh+301$5,000→ 33,159 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000.